SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-011852
Filing Date
2023-07-13
Accepted
2023-07-13 08:15:30
Documents
13
Period of Report
2023-07-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K elev-20230712x8k.htm   iXBRL 8-K 42971
  Complete submission text file 0001558370-23-011852.txt   258175

Data Files

Seq Description Document Type Size
2 EX-101.SCH elev-20230712.xsd EX-101.SCH 3265
3 EX-101.LAB elev-20230712_lab.xml EX-101.LAB 632
4 EX-101.PRE elev-20230712_pre.xml EX-101.PRE 10889
7 EXTRACTED XBRL INSTANCE DOCUMENT elev-20230712x8k_htm.xml XML 5048
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 231085770
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences